Your session is about to expire
← Back to Search
Fulvestrant for Breast Cancer
Study Summary
This trial is testing how well three different drugs work when given together to treat patients with a specific type of hormone receptor-positive breast cancer.
- Metastatic Breast Cancer
- Breast Cancer
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2012 Phase 3 trial • 514 Patients • NCT00256698Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You are pregnant or breastfeeding.You have previously received fulvestrant treatment for your advanced cancer.You have a mental illness that may affect your ability to understand and agree to participate in the study.You have cancer that has already spread to other parts of your body when you were first diagnosed.Your expected survival time is less than 6 months.If you are a man and your female partner is of childbearing age, you must use effective contraception during the study and for 8 weeks after treatment ends, if your partner is not willing to get pregnant.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are we still enrolling people in this experiment?
"Yes, this study is still recruiting patients. According to the information on clinicaltrials.gov, the trial was originally posted on May 31st, 2019 and was last updated on October 25th, 2022."
What is the primary disease that Fulvestrant has been shown to improve?
"If a patient's cancer progresses despite tamoxifen therapy, fulvestrant may be an effective treatment option."
What is the total sample size for this clinical trial?
"That is accurate. The clinicaltrials.gov website says that this research is currently looking for subjects. It was originally posted on 5/31/2019, with the most recent update on 10/25/2022. They want 124 individuals from 1 location."
Is Fulvestrant a common prescription medication?
"449 different Fulvestrant studies are currently active with 85 of them being in Phase 3. Even though a large quantity of the research is coming out of Shanghai, China, there are 24073 total locations where Fulvestrant trials are taking place."
Has Fulvestrant been cleared by the FDA for patient use?
"Although there is some evidence backing Fulvestrant's safety, it did not receive a higher score due to the lack of clinical data demonstrating its efficacy."
Share this study with friends
Copy Link
Messenger